Introgen Therapeutics
Manufacturing · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
301 Congress Ave Ste 1850, Austin, Texas...Phone Number
(512) 708-9310Website
www.introgen.comRevenue
$27.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Introgen Therapeutics
Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. Introgen is developing molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. Introgen maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale cGMP manufacturing facility.Explore more
Popular SearchesIntrogen Therapeutics IncGendux Molecular LtdGendux Pharmaceuticals LtdIntrogen Global LtdIntrogen Technical Services IncSIC Code 28,283NAICS Code 32,325Show more
Introgen Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Introgen Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Introgen Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Introgen Therapeutics
Funding: Get notified immidiatlly once Introgen Therapeutics has new funding data
Introgen Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Introgen Therapeutics recently announced quarterly report
Click to see if Introgen Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Introgen Therapeutics launches new products
Check if Introgen Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Introgen Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Introgen Therapeutics
Compare insights from companies similar to Introgen Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Introgen Therapeutics
$27.4M
51-200
Private
-
1993
DW
Deborah WilsonAssociate Vice President of Clinical Research
Company Profile Activity
Activity Insights
Introgen Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Introgen Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Introgen Therapeutics.
Introgen Therapeutics Tech Stack
A closer look at the technologies used by Introgen Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Introgen Therapeutics
Sign Up For FreeTo access detailed company insights
Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. Introgen is developing molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers... Read More
